NUVASIVE INC. NUVA (NASDAQ)

(NEW YORK)The executive vice president of marketing and development for medical device company NuVasive Inc. exercised options for 8,000 shares of common stock, according to a filing with th...READ MORE

(NEW YORK)Increasing excitement from surgeons about new bone graft substitute products will propel that market to $1.9 billion in 2012, according to a new report.READ MORE

Osiris Therapeutics Inc. announced today it entered in a deal with NuVasive Inc. to sell its business Osteocel for up to $85 million in upfront and milestone payments.READ MORE

(NEW YORK)An executive vice president of medical device company NuVasive Inc. exercised options for 8,000 shares of common stock under a prearranged trading plan, according to a Securities a...READ MORE

Among the earnings stories for Tuesday, April 22, from AP Financial News: LANCASTER, Pa. (AP) _ Fulton Financial Corp.'s profit climbed 1 percent in the first quarter as bad cr...READ MORE

(NEW YORK)The president and chief operating officer of NuVasive Inc., a medical-device company, exercised options for 6,000 shares of stock under a prearranged trading plan, according to a S...READ MORE

(NEW YORK)The chief executive of NuVasive Inc., a medical-device company, exercised options for and sold 20,000 shares of common stock, according to a Securities and Exchange Commission fili...READ MORE